(Total Views: 470)
Posted On: 10/13/2024 6:45:48 PM
Post# of 154633
2016: start HIV infant monkeys & ART studies.
Dr. Nancy Haigwood & Dr. Sacha.
Author & Co-author on news.
Co-funding from NICD.
OHSU.
2024 we know how ART's performing.
Cytodyn Oct. 7th, 2024:
“These results demonstrate a previously unappreciated synergy between CCR5 blockade and antibody neutralization that opens the door to a new approach for an HIV cure that should be explored further,” said Jonah B. Sacha, Ph.D, Chief of the Pathobiology and Immunology Division at the Oregon National Primate Research Center at Oregon Health & Science University. The study was funded by an NIH grant awarded to OHSU and led by Dr. Nancy Haigwood, Dr. Sacha, and their collaborators.
___
Expecting Dr. Sacha / Cytodyn press releases, continues.
Dr. Nancy Haigwood & Dr. Sacha.
Author & Co-author on news.
Co-funding from NICD.
OHSU.
2024 we know how ART's performing.
Cytodyn Oct. 7th, 2024:
“These results demonstrate a previously unappreciated synergy between CCR5 blockade and antibody neutralization that opens the door to a new approach for an HIV cure that should be explored further,” said Jonah B. Sacha, Ph.D, Chief of the Pathobiology and Immunology Division at the Oregon National Primate Research Center at Oregon Health & Science University. The study was funded by an NIH grant awarded to OHSU and led by Dr. Nancy Haigwood, Dr. Sacha, and their collaborators.
___
Expecting Dr. Sacha / Cytodyn press releases, continues.
(4)
(0)
